The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus

The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus

The objective is to investigate the role of clinically significant antiphospholipid antibodies (aPL) in a cohort of systemic lupus erythematosus (SLE) patients. All SLE patients followed for at least 5 years and with available aPL profile at the beginning of the follow-up in our center were studied....

Full description

Bibliographic Details
Main Authors: M. Taraborelli, M.G. Lazzaroni, N. Martinazzi, M. Fredi, I. Cavazzana, F. Franceschini, A. Tincani
Format: Article
Language:English
Published: PAGEPress Publications 2016-12-01
Series:Reumatismo
Subjects:
Systemic lupus erythematosus
antiphospholipid antibodies
antiphospholipid syndrome
thrombosis
valvulopathy.
Online Access:http://www.reumatismo.org/index.php/reuma/article/view/891

Internet

http://www.reumatismo.org/index.php/reuma/article/view/891

Similar Items